FOXO3 and cancer: Our results revealed no significant differences between FOXO-3 levels in LUT 100, respectively, lutein Nps-treated cells, compared to control cancer cells (Table 1, Table 2 and Table 5; Figure 2a, Figure 3a and Figure 6).